SCHEMBL7869455

SCHEMBL7869455

O=C(NCCO)Oc1ccc(C(=O)NS(=O)(=O)c2ccccc2)cn1

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 4/20 0.57
PTGS2 P35354 4/20 0.48
PTGS1 P23219 2/20 0.47
EGFR P00533 3/20 0.46
GABRA5 P31644 3/20 0.43
BCL2L1 Q07817 2/20 0.42
MCL1 Q07820 2/20 0.42
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALKBH2 Q6NS38 1/20 0.40
ALKBH5 Q6P6C2 1/20 0.40
FTO Q9C0B1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7869457 0.90 P4HTM (0.47) P4HTMSMN1; SMN2
SCHEMBL7871640 0.90 RAB9A (0.52) P4HTMNPC1RAB9ASMN1; SMN2
SCHEMBL7867790 0.89 MEN1 (0.48) P4HTMBCL2L1MCL1NPC1RAB9A
SCHEMBL7871609 0.89 P4HTM (0.55) P4HTMPTGS2PTGS1EGFRGABRA5
SCHEMBL7870451 0.88 NPC1 (0.46) P4HTMEGFRGABRA5BCL2L1MCL1
SCHEMBL7867895 0.88 NPC1 (0.51) P4HTMEGFRGABRA5BCL2L1MCL1
SCHEMBL9574778 0.88 P4HTM (0.43) P4HTMEGFRBCL2L1MCL1SMN1; SMN2
SCHEMBL7862856 0.88 HSP90AA1 (0.46) P4HTMEGFRGABRA5BCL2L1MCL1
SCHEMBL7871681 0.87 EGFR (0.46) P4HTMPTGS2EGFRGABRA5
SCHEMBL7874499 0.87 P4HTM (0.58) P4HTMEGFRRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed